KU Leuven develops very potent antiviral against dengue

- EN - NL
Johan Neyts: ’Even a low dose of the drug administered via the oral route
Johan Neyts: ’Even a low dose of the drug administered via the oral route proved to be very effective. What is more, the treatment is still effective when the infection is already at its peak.’  | © KU Leuven - Rob Stevens

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue. The teams collaborated closely with Janssen Pharmaceutica, N.V. The antiviral molecule is exceptionally effective against all known dengue variants and could be used for therapeutic and prevention purposes. The teams have published their findings in Nature. 

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue. The teams collaborated closely with Janssen Pharmaceutica, N.V. ...

account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login


Subscribe